Raloxifene Hydrochloride
Who holds supplier records for Raloxifene Hydrochloride? 15 organisations hold a current record for Raloxifene Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11), Italy (3) and Netherlands (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Raloxifene Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/raloxifene-hydrochloride
Reading the evidence
- 15 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
11 of the 15 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 11 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (15)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Raloxifene Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 25650 · latest filing Jan 2012
- Aurore Life SciencesIndiaCEP Company GMP cert on recordActive DMF 36445 · latest filing Oct 2021
- Cadila Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 27064 · latest filing May 2013
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 16143 · latest filing Sept 2002
- ERREGIERRE SPAItalyCEP Company GMP cert on recordActive DMF 15932 · latest filing Apr 2002
- GLOCHEM INDUSTRIES LTDIndiaCEPActive DMF 21682 · latest filing Jun 2008
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 25281 · latest filing Sept 2011
- MEDILUX LABORATORIES PVT LTDIndiaCEP Company GMP cert on recordActive DMF 39175 · latest filing Nov 2023
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 29721 · latest filing Sept 2015
- AARTI DRUGS LTDIndia Company GMP cert on recordActive DMF 21650 · latest filing May 2008
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 41611 · latest filing Mar 2025
- CAMBREX PROFARMACO MILANO SRLItaly Company GMP cert on recordActive DMF 22927 · latest filing Jul 2009
- RAKS PHARMA PVT LTDIndiaActive DMF 31952 · latest filing Aug 2017
- TAPI NL BVNetherlandsActive DMF 27969 · latest filing Mar 2014
- Apotex Pharmachem India Pvt. Ltd.IndiaCEPInactive DMF 24589 · latest filing Feb 2011
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Raloxifene Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CADILA PHARMACEUTICALS LIMITED Ankleshwar | IN | CEP 2024-387 - Rev 00 Raloxifene hydrochloride | Jun 2026 | — |
| AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2022-165 - Rev 01 Raloxifene hydrochloride | Apr 2026 | — |
| MEDILUX LABORATORIES PRIVATE LIMITED Pithampur | IN | CEP 2023-432 - Rev 00 Raloxifene hydrochloride | Dec 2024 | Inspected Nov 2025 Germany |
| APOTEX PHARMACHEM INDIA PVT. LTD Bangalore | IN | CEP 2017-097 - Rev 01 Raloxifene hydrochloride | Aug 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2024-069 - Rev 00 Raloxifene hydrochloride, Modified process | Apr 2024 | — |
| GLOCHEM INDUSTRIES PRIVATE LIMITED Hyderabad | IN | CEP 2023-123 - Rev 00 Raloxifene hydrochloride, LAXAI | Nov 2023 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2014-054 - Rev 01 Raloxifene hydrochloride | Mar 2023 | — |
| OLON S.P.A. Rodano | IT | R1-CEP 2015-171 - Rev 00 Raloxifene hydrochloride | Apr 2022 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | R1-CEP 2011-349 - Rev 00 Raloxifene hydrochloride | Nov 2020 | — |
| ERREGIERRE S.P.A. San Paolo D'Argon | IT | R1-CEP 2010-205 - Rev 00 Raloxifene hydrochloride | Sept 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Raloxifene Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- India · Inactive DMF 20163, 32898 · filed Jul 2018
- Sichuan Xieli Pharmaceutical Co LtdChina · Inactive DMF 26492 · filed Sept 2012
- TEVA PHARMACEUTICALS INDUSTRIES LTDInactive DMF 21327 · filed Feb 2008
- Germany · Inactive DMF 17415 · filed May 2004
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Raloxifene Hydrochloride is a selective estrogen receptor modulator (SERM) used primarily for the prevention and treatment of osteoporosis in postmenopausal women. In addition, it is used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and those at high risk for invasive breast cancer.
Chemical identity
- IUPAC name
- [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride
- Canonical SMILES
- C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl
- InChIKey
- BKXVVCILCIUCLG-UHFFFAOYSA-N
- Synonyms
- Evista API, evista, ly-156758, ly156758, nsc-706725, optruma, raloxifene hcl, raloxifene teva
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Estrogen Agonist/Antagonist
- Mechanism of action
- Selective Estrogen Receptor Modulators
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Raloxifene Hydrochloride?
15 organisations hold an active US FDA Type II Drug Master File or a CEP for Raloxifene Hydrochloride: APITORIA PHARMA PRIVATE LTD (India), Aurore Life Sciences (India), Cadila Pharmaceuticals Limited (India), Dr. Reddy's Laboratories Ltd. (India), ERREGIERRE SPA (Italy), GLOCHEM INDUSTRIES LTD (India), Hetero Drugs Limited (India) and MEDILUX LABORATORIES PVT LTD (India), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Raloxifene Hydrochloride Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 25650), Aurore Life Sciences (DMF 36445), Cadila Pharmaceuticals Limited (DMF 27064), Dr. Reddy's Laboratories Ltd. (DMF 16143), ERREGIERRE SPA (DMF 15932), GLOCHEM INDUSTRIES LTD (DMF 21682), Hetero Drugs Limited (DMF 25281) and MEDILUX LABORATORIES PVT LTD (DMF 39175) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Raloxifene Hydrochloride records mean?
4 organisations have only inactive Type II DMFs for Raloxifene Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Raloxifene Hydrochloride have a European Certificate of Suitability?
Yes. 10 organisations hold a valid CEP for Raloxifene Hydrochloride on the EDQM register, including CADILA PHARMACEUTICALS LIMITED Ankleshwar (IN), AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), MEDILUX LABORATORIES PRIVATE LIMITED Pithampur (IN), APOTEX PHARMACHEM INDIA PVT. LTD Bangalore (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and GLOCHEM INDUSTRIES PRIVATE LIMITED Hyderabad (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Raloxifene Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Raloxifene Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.